On October 24, twenty-three participants representing 14 companies gained an insight into the R&D and marketing activities of the two Viennese companies Braincon Handels-GmbH and Biomedica Group. After the presentation of both companies, the newly developed DCXpert of AMS Braincon for room and surface disinfection that is used for preventing nosocomial infections in hospitals was at center stage. The joint venture DCX Technologies GmbH was specifically founded for distribution and services and professional advice with equal contributions from Braincon and Biomedica. Both companies want to combine their knowhow for international sales and marketing and the future development of DCXpert. The introduction of the companies was followed by a very productive discussion engaging the participants as well as the hosts and CEOs Dr. Stefan Marenzi (Biomedica), Dr. Bernhard Küenburg (Biomedica and DCX Technologies) and Davul Ljuhar (Braincon). The networking in subsequence was accompanied by a practical product presentation of the DCXpert while beverages and snacks were served.